Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 3,575 shares at $6.47 ($23K) on 2016-03-21, disclosed to the SEC on 2016-03-22.
Scheduled sale ($23k) by SVP, Clinical R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |
| ARIA | SELL | 2015-03-23 | $60K | — | Filing → |